Sign inJoin waitlistJoin the waitlist

SC

Stephen Chui

Hematology & Oncology

Credentials: ·

History

Hematology and Medical Oncology
Internal Medicine

Research

Atezolizumab and Nab-Paclitaxel in Advanced Triple-Negative Breast Cancer
New England Journal of Medicine · 2018 · 3,425 citations
Atezolizumab plus nab-paclitaxel as first-line treatment for unresectable, locally advanced or metastatic triple-negative breast cancer (IMpassion130): updated efficacy results…
The Lancet Oncology · 2020 · 978 citations
Neoadjuvant atezolizumab in combination with sequential nab-paclitaxel and anthracycline-based chemotherapy versus placebo and chemotherapy in patients with early-stage…
The Lancet · 2020 · 869 citations

Hope Rugo
9 papers
LE
Leisha Emens
9 papers
Eric Winer
7 papers
Sylvia Adams
6 papers
Herbert Lyerly
5 papers
KK
Kathleen Kemmer
5 papers
Angela DeMichele
4 papers
Anne Wallace
4 papers
Anthony Elias
4 papers
Claudine Isaacs
4 papers
DT
Debasish Tripathy
4 papers
Douglas Yee
4 papers